Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenakshi Anurag

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Molecular Biosystems|September 19, 2009
Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosisMeenakshi Anurag, Debasis Dash
Journal of the National Cancer Institute|March 20, 2020
Response to Jézéquel, Patsouris, Guette, et alMeenakshi Anurag, Matthew J Ellis
Oncotarget|December 18, 2018
DNA damage repair defects as a new class of endocrine treatment resistance driverMeenakshi Anurag, Matthew J Ellis, Svasti Haricharan
Molecular Biosystems|October 27, 2011
Location of disorder in coiled coil proteins is influenced by its biological role and subcellular localization: a GO-based study on human proteomeMeenakshi Anurag, Gajinder Pal Singh, Debasis Dash
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2019
CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?Meenakshi Anurag, Svasti Haricharan, Matthew J Ellis
Expert Review of Proteomics|April 17, 2023
How valuable can proteogenomics be in clinical breast cancer research?Anh M Tran-Huynh, Matthew V Holt, Meenakshi Anurag
BMC Pharmacology|July 8, 2011
A web server for predicting inhibitors against bacterial target GlmU proteinDeepak Singla, Meenakshi Anurag, Debasis Dash, et al.
Breast (Edinburgh, Scotland)|December 17, 2019
Endocrine therapy resistance: new insightsJonathan T Lei, Meenakshi Anurag, Svasti Haricharan, et al.
Molecular Cancer Research : MCR|August 5, 2016
Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M CheckpointJin-Ah Kim, Meenakshi Anurag, Jamunarani Veeraraghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance DriversMeenakshi Anurag, Nindo Punturi, Jeremy Hoog, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Molecular Biosystems|September 19, 2009
Unraveling the potential of intrinsically disordered proteins as drug targets: application to Mycobacterium tuberculosisMeenakshi Anurag, Debasis Dash
Journal of the National Cancer Institute|March 20, 2020
Response to Jézéquel, Patsouris, Guette, et alMeenakshi Anurag, Matthew J Ellis
Oncotarget|December 18, 2018
DNA damage repair defects as a new class of endocrine treatment resistance driverMeenakshi Anurag, Matthew J Ellis, Svasti Haricharan
Molecular Biosystems|October 27, 2011
Location of disorder in coiled coil proteins is influenced by its biological role and subcellular localization: a GO-based study on human proteomeMeenakshi Anurag, Gajinder Pal Singh, Debasis Dash
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 7, 2019
CDK4/6 Inhibitor Biomarker Research: Are We Barking Up the Wrong Tree?Meenakshi Anurag, Svasti Haricharan, Matthew J Ellis
Expert Review of Proteomics|April 17, 2023
How valuable can proteogenomics be in clinical breast cancer research?Anh M Tran-Huynh, Matthew V Holt, Meenakshi Anurag
BMC Pharmacology|July 8, 2011
A web server for predicting inhibitors against bacterial target GlmU proteinDeepak Singla, Meenakshi Anurag, Debasis Dash, et al.
Breast (Edinburgh, Scotland)|December 17, 2019
Endocrine therapy resistance: new insightsJonathan T Lei, Meenakshi Anurag, Svasti Haricharan, et al.
Molecular Cancer Research : MCR|August 5, 2016
Amplification of TLK2 Induces Genomic Instability via Impairing the G2-M CheckpointJin-Ah Kim, Meenakshi Anurag, Jamunarani Veeraraghavan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2018
Comprehensive Profiling of DNA Repair Defects in Breast Cancer Identifies a Novel Class of Endocrine Therapy Resistance DriversMeenakshi Anurag, Nindo Punturi, Jeremy Hoog, et al.
Pageof 6